Bausch + Lomb gains after earnings beat - MSN

Vaughan, Canada-based Bausch + Lomb projected $840M–$890M in adjusted EBITDA on $4.6B–$4.7B in revenue for 2024, compared to $4.56B in the consensus. More on Bausch + …

$840
OFF

Bausch + Lomb Gains After Earnings Beat - MSN

2 weeks from now

Vaughan, Canada-based Bausch + Lomb projected $840M–$890M in adjusted EBITDA on $4.6B–$4.7B in revenue for 2024, compared to $4.56B in the consensus. More on Bausch + …

msn.com

9%
OFF

Bausch & Lomb’s Stock Soars 9% After Earnings Beat - MSN

2 weeks from now

Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported adjusted fourth-quarter profit that topped estimates and offered upbeat revenue guidance for …

msn.com

11%
OFF

Bausch + Lomb Stock Jumps After Better-Than-Expected Earnings …

2 weeks from now

Bausch + Lomb Corp. shares jumped more than 11% Wednesday after the eye-care company posted better-than-expected results and guidance, boosted by sales of its pharmaceutical …

msn.com

19%
OFF

Bausch + Lomb Third Quarter 2024 Earnings: Beats Expectations

2 weeks from now

Nov 1, 2024 · Bausch + Lomb ( NYSE:BLCO ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.20b (up 19% from 3Q 2023...

yahoo.com

18%
OFF

Bausch + Lomb Shares Climb On Earnings Beat, Raised Outlook

2 weeks from now

May 1, 2024 · VAUGHAN, Ontario - Bausch + Lomb Corporation (NYSE:BLCO), a global leader in eye health, reported a robust first quarter of 2024, with revenue climbing 18% to $1.099 billion, …

investing.com

$4.72
OFF

Bausch + Lomb Posts Top-line Beat, Raises Full-year Outlook

2 weeks from now

Oct 30, 2024 · Bausch + Lomb raised its full-year 2024 revenue guidance to a range of $4.725 billion to $4.825 billion, up from its previous outlook of $4.7 billion to $4.8 billion. The new …

investing.com

8%
OFF

Bausch & Lomb Earnings: Broad-Based Growth And Margin Gains …

2 weeks from now

Oct 30, 2024 · Narrow-moat Bausch & Lomb reported solid third-quarter earnings that came in a tad higher than our expectations. Total sales of $1.2 billion were up 18.8% year over year …

morningstar.com

9%
OFF

Bausch & Lomb's Stock Soars 9% After Earnings Beat

2 weeks from now

Feb 21, 2024 · Bausch & Lomb Corp.'s stock soared 10% early Wednesday after the eye-care company reported adjusted fourth-quarter profit that topped estimates and offered upbeat …

morningstar.com

$0.17
OFF

Bausch + Lomb (BLCO) Q3 Earnings And Revenues Top Estimates

2 weeks from now

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.22 per share a year …

msn.com

22%
OFF

Bausch + Lomb: Q3 Earnings Snapshot - Yahoo Finance

2 weeks from now

Oct 30, 2024 · Bausch + Lomb expects full-year revenue in the range of $4.72 billion to $4.83 billion. Bausch + Lomb shares have risen 22% since the beginning of the year. The stock has …

yahoo.com

$0.24
OFF

Bausch + Lomb Corporation (BLCO) Latest Stock News - Seeking …

2 weeks from now

Jan 8, 2025 · Bausch + Lomb gains after earnings beat SA News Wed, Feb. 21, 2024 3 Comments Bausch + Lomb Non-GAAP EPS of $0.24 beats by $0.07, revenue of $1.17B beats …

seekingalpha.com

$0.16
OFF

Bausch + Lomb (BLCO) Expected To Beat Earnings Estimates: Can

2 weeks from now

Oct 25, 2023 · For the last reported quarter, it was expected that Bausch + Lomb would post earnings of $0.16 per share when it actually produced earnings of $0.18, delivering a surprise …

nasdaq.com

$1.12
OFF

Bausch Health Q3 Earnings And Revenues Top, Xifaxan Boosts …

2 weeks from now

Adjusted earnings per share of $1.12 beat the Zacks Consensus Estimate of $1.03. The reported figure increased from $1.03 in the year-ago quarter due to higher revenues. ... Bausch + Lomb …

msn.com

8%
OFF

Bausch + Lomb (BLCO) Q3 Earnings: Taking A Look At Key Metrics …

2 weeks from now

Oct 30, 2024 · For the quarter ended September 2024, Bausch + Lomb (BLCO) reported revenue of $1.2 billion, up 18.8% over the same period last year. EPS came in at $0.17, compared to …

nasdaq.com

6%
OFF

Bausch + Lomb's U.S. Shares Tracking Record Gain After Q4 Beat

2 weeks from now

Feb 21, 2024 · ** U.S.-listed shares of Canada's Bausch + Lomb Corp BLCO up 10.6% at $16.14 on Weds, 6-week high, after eye care firm's results top expectations ** BLCO on course for …

tradingview.com

7%
OFF

Why Bausch + Lomb Stock Soared By Over 7% On Monday

2 weeks from now

Oct 14, 2024 · Buffeted by these strong winds, Bausch + Lomb's stock price rose over 7% in the day's trading session. Eyes on the prize Of the two news items, the buyout one had the bigger …

nasdaq.com

FAQs about Bausch + Lomb gains after earnings beat - MSN Coupon?

How did Bausch & Lomb perform in Q3 2024?

Bausch + Lomb posted Q3 2024 earnings on October 30, 2024, reporting an EPS of $0.17, which topped analysts' consensus estimates of $0.16 by $0.01. Quarterly revenue rose 18.8% year-over-year to $1.20 billion, above analyst estimates of $1.17 billion. ...

Why did Bausch & Lomb shares rise 11% Wednesday?

Bausch + Lomb shares rose more than 11% Wednesday after the positive earnings news. Bausch + Lomb Corp. ( BLCO) shares jumped more than 11% Wednesday after the eye-care company posted better-than-expected results and guidance, boosted by sales of its pharmaceutical products. ...

How many times has Bausch & Lomb surpassed consensus EPS estimates?

Over the last four quarters, the company has surpassed consensus EPS estimates two times. Bausch + Lomb, which belongs to the Zacks Medical Services industry, posted revenues of $1.2 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 2.54%. This compares to year-ago revenues of $1.01 billion. ...

What will Bausch & Lomb's full-year revenue look like?

Bausch + Lomb predicts full-year revenue will be in the range of $4.6 billion to $4.7 billion, higher than what analysts were expecting . Shares of Bausch + Lomb had fallen to an all-time low earlier this month, and even with Wednesday's surge to $16.26 at 3:06 p.m. ET, they’re still down about 14% year over year. ...

How much did Bausch & Lomb make?

Revenues from Bausch + Lomb totaled $1.19 billion, up 19% year over year. The figure missed both the Zacks Consensus Estimate and our model estimate of $1.2 billion. Bausch + Lomb’s revenues increased 10% organically on a year-over-year basis, driven by growth across all business units. ...

What do analysts expect from Bausch & Lomb?

Seven analysts surveyed by Zacks expected $1.17 billion. Bausch + Lomb expects full-year revenue in the range of $4.72 billion to $4.83 billion. Bausch + Lomb shares have risen 22% since the beginning of the year. The stock has increased 27% in the last 12 months. ...